Ashfaq R - Search Results

1

Immunohistochemical evaluation of heat shock proteins in normal and preinvasive lesions of the cervix.

Castle PE, Ashfaq R, Ansari F, Muller CY. Castle PE, et al. Among authors: ashfaq r. Cancer Lett. 2005 Nov 18;229(2):245-52. doi: 10.1016/j.canlet.2005.06.045. Epub 2005 Aug 19. Cancer Lett. 2005. PMID: 16112431

2

Analysis of genetic copy number changes in cervical disease progression.

Policht FA, Song M, Sitailo S, O'Hare A, Ashfaq R, Muller CY, Morrison LE, King W, Sokolova IA. Policht FA, et al. Among authors: ashfaq r. BMC Cancer. 2010 Aug 16;10:432. doi: 10.1186/1471-2407-10-432. BMC Cancer. 2010. PMID: 20712890 Free PMC article.

3

Microsatellite instability among individuals of Hispanic origin with colorectal cancer.

Gupta S, Ashfaq R, Kapur P, Afonso BB, Nguyen TP, Ansari F, Boland CR, Goel A, Rockey DC. Gupta S, et al. Among authors: ashfaq r. Cancer. 2010 Nov 1;116(21):4965-72. doi: 10.1002/cncr.25486. Cancer. 2010. PMID: 20665498 Free PMC article.

4

Allelic loss and microsatellite alterations of chromosome 3p14.2 are more frequent in recurrent cervical dysplasias.

Lin WM, Michalopulos EA, Dhurander N, Cheng PC, Robinson W, Ashfaq R, Coleman RL, Muller CY. Lin WM, et al. Among authors: ashfaq r. Clin Cancer Res. 2000 Apr;6(4):1410-4. Clin Cancer Res. 2000. PMID: 10778971

5

BRCAPAP: feasibility of clinical BRCA testing on liquid-based cervical cytology: implications for biomarker development.

Muller CY, Schorge JO, Tomlinson GE, Ashfaq R. Muller CY, et al. Among authors: ashfaq r. Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1534-7. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15342457

6

Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development.

Lea JS, Ashfaq R, Muneer S, Burbee DG, Miller DS, Minna JD, Muller CY. Lea JS, et al. Among authors: ashfaq r. J Soc Gynecol Investig. 2004 Jul;11(5):329-37. doi: 10.1016/j.jsgi.2003.12.008. J Soc Gynecol Investig. 2004. PMID: 15219888

7

Chromosome 4 deletions are frequent in invasive cervical cancer and differ between histologic variants.

Sherwood JB, Shivapurkar N, Lin WM, Ashfaq R, Miller DS, Gazdar AF, Muller CY. Sherwood JB, et al. Among authors: ashfaq r. Gynecol Oncol. 2000 Oct;79(1):90-6. doi: 10.1006/gyno.2000.5922. Gynecol Oncol. 2000. PMID: 11006038

8

Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.

Lin WM, Forgacs E, Warshal DP, Yeh IT, Martin JS, Ashfaq R, Muller CY. Lin WM, et al. Among authors: ashfaq r. Clin Cancer Res. 1998 Nov;4(11):2577-83. Clin Cancer Res. 1998. PMID: 9829719

9

Genetic changes during the multistage pathogenesis of human papillomavirus positive and negative vulvar carcinomas.

Flowers LC, Wistuba II, Scurry J, Muller CY, Ashfaq R, Miller DS, Minna JD, Gazdar AF. Flowers LC, et al. Among authors: ashfaq r. J Soc Gynecol Investig. 1999 Jul-Aug;6(4):213-21. doi: 10.1016/s1071-5576(99)00023-4. J Soc Gynecol Investig. 1999. PMID: 10486784

10

Telomerase activity and expression of its RNA component in cervical lesions.

Yashima K, Ashfaq R, Nowak J, Von Gruenigen V, Milchgrub S, Rathi A, Albores-Saavedra J, Shay JW, Gazdar AF. Yashima K, et al. Among authors: ashfaq r. Cancer. 1998 Apr 1;82(7):1319-27. Cancer. 1998. PMID: 9529024

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters